- Adults (18-64 years)
- General population
- Hospital
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute COVID-19
- Influenza
- Avian Influenza
- Pharmacological intervention
- Immunomodulator
- Baricitinib
- Statins
- Simvastatin
Pathogen: Influenza A(H5N1) virus
- Adults (18-64 years)
- General population
- Hospital
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute COVID-19
- Influenza
- Avian Influenza
- Adults (18-64 years)
- Community
- Primary care
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute COVID-19
- Influenza
- Avian Influenza
- Pharmacological intervention
- Nitric Oxide Nasal Spray
- Adults (18-64 years)
- Hospital
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute COVID-19
- Influenza
- Avian Influenza
- Pharmacological intervention
- Immunomodulator
- Corticosteroid
- Baloxavir
- Oseltamivir
- Adults (18-64 years)
- Elderly (≥65 years)
- Infants (<1 year)
- Adolescents (12-17 years)
- Children (1-11 years)
- Hospital
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Influenza
- Avian Influenza
- Pharmacological intervention
- Antivirals
- Corticosteroid
- Baloxavir
- Oseltamivir
- Adults (18-64 years)
- General population
- Elderly (≥65 years)
- Community
- Non-hospital health centre
- Long-term care facility
- Influenza virus
- Influenza A(H5N1) virus
- Influenza A(H7N9) virus
- Avian Influenza
- Pharmacological intervention
- Vaccination